Inflammatory Response Clinical Trial
Official title:
The Combined Influence of Blueberry and Banana Consumption on Metabolic Recovery From 75-km Cycling Exercise Stress
Verified date | January 2018 |
Source | Appalachian State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The PURPOSE of this study is to investigate the combined influence of 2-weeks blueberry
ingestion and banana ingestion (during exercise) on performance and in mitigating metabolic
perturbation, immune dysfunction, and increase in inflammation following a 75-km cycling time
trial. We hypothesize that the combination of 2-weeks ingestion of blueberries (versus
placebo) and acute ingestion of bananas (versus water alone) during 75-km cycling will:
1. Enhance performance.
2. Attenuate the magnitude of metabolic perturbation due to exercise (using a targeted
panel of metabolites) which may be associated with increased plasma levels of beneficial
gut-derived phenolics.
3. Attenuate post-exercise inflammation (as measured with cytokines, muscle damage markers,
regulatory lipid mediators, ex-vivo monocyte cell cultures, and targeted immune proteins
including S100A8 and S100A12).
4. Counter post-exercise downturns in innate immune function (natural killer cell lytic
activity), and viral defense (using an ex-vivo cell culture with Hela cells).
Status | Completed |
Enrollment | 60 |
Est. completion date | December 15, 2017 |
Est. primary completion date | December 15, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility |
Inclusion Criteria: - Male or female. - Ages 18-55 years. - Non-smoker. - Regularly compete in road races (category 1 to 5) and/or are capable of cycling 75 km in a laboratory setting (using own bicycles on CompuTrainer training systems). - Agree to train normally, maintain weight, and avoid the regular use of large-dose vitamin and mineral supplements, herbs, and medications that influence inflammation and immune function (especially Advil, Motrin, aspirin, and similar anti-inflammatory drugs) for the duration of the 2.5-week study. If in doubt, please discuss your supplement and medication use with the Research Manager during orientation (Courtney Goodman). - Categorized as "low risk" using the American College of Sports Medicine screening questionnaire. - Generally healthy and without chronic disease including cardiovascular disease (e.g., heart disease, stroke), cancer, type 1 and 2 diabetes, rheumatoid arthritis. Exclusion Criteria: - Inability to comply with study requirements. - Body weight below 100 pounds. - Pregnant or breastfeeding. - Any other concurrent condition which, in the opinion of the primary investigator (PI), would preclude participation in this study or interfere with compliance. - Current diagnosis of cardiovascular disease, diabetes, or cancer (except for non-melanoma skin cancer). - History of allergic reactions to blueberries or bananas. |
Country | Name | City | State |
---|---|---|---|
United States | North Carolina Research Campus, Human Performance Lab | Kannapolis | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Appalachian State University | Dole Food Company |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Inflammation | Cytokines | Change from pre-supplementation to post-2-weeks supplementation, and to six post-exercise time points (0, 1.5, 3.0, 5.0, 21, 45 hours) | |
Secondary | Metabolite shifts | Targeted panel of metabolites | Change from pre-supplementation to post-2-weeks supplementation, and to six post-exercise time points (0, 1.5, 3.0, 5.0, 21, 45 hours) | |
Secondary | Natural killer cell activity | Innate immune function | Change from pre-supplementation to post-2-weeks supplementation, and to six post-exercise time points (0, 1.5, 3.0, 5.0, 21, 45 hours) | |
Secondary | Exercise performance | 75-km cycling time trial, with or without bananas | After the 2-week period of blueberry or placebo intake | |
Secondary | Targeted proteomics | Targeted panel of 24 immune proteins including S100A8 and S100A12 | Change from pre-supplementation to post-2-weeks supplementation, and to six post-exercise time points (0, 1.5, 3.0, 5.0, 21, 45 hours) | |
Secondary | Muscle damage | Creatine kinase | Change from pre-supplementation to post-2-weeks supplementation, and to six post-exercise time points (0, 1.5, 3.0, 5.0, 21, 45 hours) | |
Secondary | Lipid mediators | Arachadonic acid oxidized derivatives from LC-MS-MS analysis | Change from pre-supplementation to post-2-weeks supplementation, and to six post-exercise time points (0, 1.5, 3.0, 5.0, 21, 45 hours) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Not yet recruiting |
NCT06434701 -
Severe COVID-19 Infection in Children Presenting to EDs in Israel and England
|
N/A | |
Enrolling by invitation |
NCT05020210 -
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
|
||
Completed |
NCT04084301 -
Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury
|
N/A | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Not yet recruiting |
NCT05990933 -
Role of Adrenaline in in the Inflammatory Response in Diabetes
|
N/A | |
Not yet recruiting |
NCT06016023 -
Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
|
||
Not yet recruiting |
NCT04608643 -
Inflammatory Markers and Cbc Indices in Severely Malnourished Children
|
||
Recruiting |
NCT01934049 -
Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty
|
Phase 4 | |
Recruiting |
NCT01417923 -
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
|
Phase 4 | |
Terminated |
NCT01377441 -
Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia.
|
Phase 4 | |
Completed |
NCT01301079 -
Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia
|
Phase 3 | |
Terminated |
NCT00578578 -
Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
|
Phase 4 | |
Recruiting |
NCT04611334 -
The Effects of HRV Biofeedback on Chronic Kidney Disease Patient.
|
N/A | |
Recruiting |
NCT03510702 -
SCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUS
|
||
Not yet recruiting |
NCT06450704 -
Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders
|
N/A | |
Not yet recruiting |
NCT05754294 -
Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.
|
||
Not yet recruiting |
NCT04386525 -
Omega 3 and Ischemic Stroke; Fish Oil as an Option
|
Phase 4 | |
Completed |
NCT04864600 -
CANDLE - A Study of Acute Health Effects of Exposure to Particles Generated by Candles
|
N/A | |
Completed |
NCT04014439 -
Relationship Between NLR and Prealbumin Levels With Diaphragm Thickness
|